GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹479 Cr | ₹466 Cr | ₹176 Cr | ₹255 Cr | ₹283 Cr |
What is the latest Total Non-Current Liabilities ratio of GRANULES INDIA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹479 Cr |
| Mar2025 | ₹466 Cr |
| Mar2024 | ₹176 Cr |
| Mar2023 | ₹255 Cr |
| Mar2022 | ₹283 Cr |
How is Total Non-Current Liabilities of GRANULES INDIA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹479 Cr | 2.81 | |
| Mar2025 | ₹466 Cr | 164.71 | |
| Mar2024 | ₹176 Cr | -30.89 | |
| Mar2023 | ₹255 Cr | -9.94 | |
| Mar2022 | ₹283 Cr | - | |
Compare Total Non-Current Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹23,055.7 Cr | -0.3% | -0.3% | 62% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,861.0 Cr | -2% | -6.1% | 12.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,319.0 Cr | 3.2% | 5.3% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,153.0 Cr | -1.9% | -2.9% | 32.7% | Stock Analytics | |
| CIPLA | ₹107,406.0 Cr | -1.5% | -4% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,362.0 Cr | -2.7% | 4.2% | -1.2% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | -0.3% |
-0.3% |
62% |
| SENSEX | 0.2% |
-4.6% |
-9.6% |
You may also like the below Video Courses